⌘K

Login Start Free

Home/Filings/4/0001209191-09-010087

4//SEC Filing

Standring David 4

Accession 0001209191-09-010087

CIK 0001093649other

View on SEC.gov Company Profile

Filed

Feb 17, 7:00 PM ET

Accepted

Feb 18, 4:30 PM ET

Size

5.8 KB

Accession

0001209191-09-010087

Insider Transaction Report

Form 4

Period: 2009-02-13

IDENIX PHARMACEUTICALS INCIDIX

Standring David

EVP, Biology

Transactions

Award
Employee Stock Option (Right to Buy)
2009-02-13+45,000→ 45,000 total
Exercise: $5.46Exp: 2019-02-12→ Common Stock (45,000 underlying)

Footnotes (1)

[F1]This option vests in 48 equal monthly installments beginning on February 28, 2009.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

IDENIX PHARMACEUTICALS INC

CIK 0001093649

Entity typeother

Related Parties

1

filerCIK 0001428085

Filing Metadata

Form type: 4
Filed: Feb 17, 7:00 PM ET
Accepted: Feb 18, 4:30 PM ET
Size: 5.8 KB

View on SEC.gov